Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity - Torres-Machorro, Adriana; Anguiano-Álvarez, Victor Manuel; Grimaldo-Gómez, Flavio Adrian; Rodríguez-Zanella, Hugo; Cortina de la Rosa, Evelyn; Mora-Canela, Sergio; Lerma, Claudia; García-Cruz, Edgar; Ramos-Enriquez, Ángel; Ramirez-Marroquin, Samuel; Izaguirre-Ávila, Raúl; Rojas-Velasco, Gustavo (Thrombosis research, 2020)
Keywords: Autopsy; COVID-19; Critical Illness; Hematology, Oncology, and Palliative Medicine; Humans; Letter to the Editors-in-Chief; Pandemics; Patients; Prospective Studies; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis - drug therapy; DD; LMWH; LDH; aPTT; DVT; PT; VTE; UFH; ICU; HS-CRP; ADP; ASA; Deep vein thrombosis; prothrombin time; Low molecular weight heparin; Lactate Dehydrogenase; Acetylsalicylic acid; D-Dimer; Intensive care unit; Unfractionated heparin; activated partial thromboplastin time; adenosine diphosphate; High sensitivity C-Reactive protein; Venous thromboembolism